Polymorphisms in the MLL breakpoint cluster region (BCR)

@article{EchlinBell2003PolymorphismsIT,
  title={Polymorphisms in the MLL breakpoint cluster region (BCR)},
  author={Deborah R. Echlin-Bell and Lydia L. Smith and Loretta Y. Li and Pamela L. Strissel and Reiner Strick and Vandana Gupta and Jhula Banerjee and R. Larson and Mary V. Relling and Susan C. Raimondi and Yasuhide Hayashi and Tomohiko Taki and Nancy J. Zeleznik-Le and Janet D. Rowley},
  journal={Human Genetics},
  year={2003},
  volume={113},
  pages={80-91}
}
The MLL gene is involved in many chromosomal translocations leading to both acute myeloid and lymphoid leukemia. Some patients treated for primary malignancies with chemotherapeutic agents that inhibit DNA topoisomerase II (topo II) develop treatment-related leukemia (t-AML) caused by MLL gene rearrangement. Whether these patients are unusually susceptible to anti-topo II drugs, or whether this is a random adverse event is unknown. To discover genetic polymorphisms that may predispose patients… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 68 references

Trinucleotide repeat polymorphism at five disease loci in mixed Hungarian population.

American journal of medical genetics • 1999
View 4 Excerpts
Highly Influenced

Aetiology of acute leukaemia.

Lancet • 1997
View 1 Excerpt
Highly Influenced

Similar Papers

Loading similar papers…